Drug Shortage Report for VAN-DORZOLAMIDE-TIMOLOL
Report ID | 38620 |
Drug Identification Number | 02451271 |
Brand name | VAN-DORZOLAMIDE-TIMOLOL |
Common or Proper name | Dorzolamide-Timolol |
Company Name | VANC PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
Strength(s) | 5MG 20MG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 10 |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-10-31 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-02-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2639 VIKING WAY, UNIT 210 RICHMOND, BRITISH COLUMBIA CANADA V6V 3B7 |
Company contact information | info@vancpharm.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-02-05 | French | Compare |
v1 | 2018-02-05 | English | Compare |
Showing 1 to 2 of 2